scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0301-472X(99)00057-0 |
P698 | PubMed publication ID | 10390194 |
P2093 | author name string | Farcet JP | |
Roussel B | |||
Agrawal S | |||
Delfau-Larue MH | |||
Jacob MC | |||
Sotto JJ | |||
Bensa JC | |||
Plumas J | |||
Chaperot L | |||
Molens JP | |||
Gressin R | |||
P2860 | cites work | Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes | Q24338522 |
Biological properties of interleukin 10. | Q35345564 | ||
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes | Q36230021 | ||
Interleukin 1: an immunological perspective | Q39476892 | ||
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas | Q40965557 | ||
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen | Q41694124 | ||
Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. | Q42943512 | ||
Regulation of human cytolytic lymphocyte responses by interleukin-12 | Q43525703 | ||
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes | Q45771097 | ||
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells | Q46578425 | ||
Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. | Q46863693 | ||
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10 | Q56987761 | ||
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma | Q67718951 | ||
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumo | Q70911105 | ||
Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas | Q72046341 | ||
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands | Q72336933 | ||
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer | Q72663515 | ||
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha | Q72752101 | ||
Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomas | Q74303458 | ||
P433 | issue | 7 | |
P304 | page(s) | 1185-1193 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Experimental Hematology | Q5421109 |
P1476 | title | Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas. | |
P478 | volume | 27 |
Q78445437 | Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas |
Q74336550 | Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma |
Q33929813 | From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas. |
Q36294042 | HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis |
Q44791845 | Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells |
Q73129235 | Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: aborted activation and G1 blockade induced by cell-cell contact |
Search more.